Biotechnology
Biotechnology platforms and systems, including gene editing, cell therapy, and synthetic biology, enable groundbreaking treatments for conditions such as genetic disorders, cancer, and autoimmune diseases. Using innovative technologies to advance diagnostics and therapeutics is at the heart of Perdigó’s mission.
New biotechnology developers face technical challenges such as ensuring precise genetic modifications, achieving high efficiency in cell therapy production, and maintaining the viability and functionality of engineered cells. Additionally, integrating advanced bioinformatics tools and scaling these technologies to meet clinical and commercial demands present significant complexities. Regulatory compliance and navigating the evolving landscape of global health standards are also critical.
Emerging trends such as personalised medicine and regenerative therapies are reshaping the biotechnology market. Meanwhile, the rise of connected biotechnologies, which leverage data analytics and cloud computing, holds promise for more proactive and informed healthcare decisions, despite the barriers raised by data security and interoperability.
How Perdigó can help?
At Perdigó, the core capabilities to deliver the biotechnology platforms that will enable the next generation of therapeutics. Perdigó harness the latest technologies and scientific breakthroughs to develop equipment tailored to the unique needs of the life sciences community.
The company expertise in high-tech product development and automation of systems help overcome technical barriers, providing trustworthy results, scaling productivity, optimising precision and reproducibility, and relieving users from tedious repetitive and error-prone tasks, delivering value to the lab.
Find out what clients say about Perdigó
“Perdigó’s showed great commitment to deliver groundbreaking technology in the field of IVF, demostrating deep engineering and medical device expertise.”
